ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

SDEV vs TENX // PIOTROSKI F-SCORE QUALITY

Stablecoin Development Corporation (NYSE) VS. Tenax Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: SDEV 1 — TENX 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SDEV VS. TENX) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC SDEV TENX SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -10.68% — — TIE /fcf-yield <GO>
Operating Margin — — — TIE /operating-margins <GO>
Net Profit Margin — — — TIE /net-margins <GO>
Revenue Growth (YoY) — — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 6.10% 0.00% +6.10 SDEV /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 0.23 — TIE /balance-sheet <GO>
Piotroski F-Score Quality ACTIVE 2/9 2/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 43.9 45.2 -1.30 TENX /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $67.3M $67.4M -$95.4K TENX /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR SDEV REV TENX REV SDEV GROSS % TENX GROSS % SDEV FCF TENX FCF
FY 2025 $23.6M $157.9M — — -$8.4M -$35.8M
FY 2024 $9.8M $54.6M 66.3% — -$7.5M -$14.8M
FY 2023 $11.5M $23.1M — — -$4.1M -$5.9M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SDEV // BETA —
TENX // BETA —